ArticleInternational journal of clinical oncology2026
Moderately hypofractionated intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: five-year results from a single-institution study in Japan.
Wataru Anno et al.PubMed ↗Publisher ↗
No numbers read from the abstract.